Latest Insider Transactions at Aziyo Biologics, Inc. (AZYO)
This section provides a real-time view of insider transactions for Aziyo Biologics, Inc. (AZYO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AZIYO BIOLOGICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AZIYO BIOLOGICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2025
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,019
-2.44%
|
$8,019
$1.81 P/Share
|
|
Jun 21
2025
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,473
+6.39%
|
-
|
|
Jun 10
2025
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,951
-4.45%
|
$3,951
$1.99 P/Share
|
|
Jun 10
2025
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+12.34%
|
-
|
|
Jun 10
2025
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,664
-3.05%
|
$9,664
$1.99 P/Share
|
|
Jun 10
2025
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,084
+7.89%
|
-
|
|
Jun 10
2025
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,461
-1.26%
|
$4,461
$1.99 P/Share
|
|
Jun 10
2025
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+3.4%
|
-
|
|
Mar 10
2025
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
12,413
-1.76%
|
$24,826
$2.89 P/Share
|
|
Mar 10
2025
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
29,000
+7.57%
|
-
|
|
Mar 10
2025
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,706
-3.57%
|
$32,118
$3.0 P/Share
|
|
Mar 10
2025
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,083
+8.28%
|
-
|
|
Mar 10
2025
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,613
-5.7%
|
$13,839
$3.0 P/Share
|
|
Mar 10
2025
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+13.38%
|
-
|
|
Mar 08
2025
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,287
+0.4%
|
-
|
|
Feb 03
2025
|
High Cape Capital, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
840,000
+4.23%
|
$1,680,000
$2.5 P/Share
|
|
Dec 10
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,461
-1.38%
|
$17,844
$4.29 P/Share
|
|
Dec 10
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+3.72%
|
-
|
|
Dec 10
2024
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,726
-4.88%
|
$54,904
$4.29 P/Share
|
|
Dec 10
2024
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,083
+8.79%
|
-
|
|
Dec 10
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,950
-5.46%
|
$15,800
$4.29 P/Share
|
|
Dec 10
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+14.73%
|
-
|
|
Sep 10
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10,527
-3.28%
|
$42,108
$4.14 P/Share
|
|
Sep 10
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
29,500
+8.41%
|
-
|
|
Sep 10
2024
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,664
-3.67%
|
$38,656
$4.14 P/Share
|
|
Sep 10
2024
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,084
+9.32%
|
-
|
|
Sep 10
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,951
-6.19%
|
$15,804
$4.14 P/Share
|
|
Sep 10
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+16.38%
|
-
|
|
Aug 12
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
17,840
-5.8%
|
$35,680
$2.84 P/Share
|
|
Aug 12
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+13.97%
|
-
|
|
Aug 12
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,800
-23.55%
|
$31,600
$2.84 P/Share
|
|
Aug 12
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+42.7%
|
-
|
|
Aug 12
2024
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
58,659
-20.06%
|
$117,318
$2.84 P/Share
|
|
Aug 12
2024
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
162,500
+35.72%
|
-
|
|
Jul 31
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
105,080
+28.96%
|
$105,080
$1.43 P/Share
|
|
Jul 30
2024
|
High Cape Capital, L.P. Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,101,577
+18.76%
|
$2,101,577
$1.43 P/Share
|
|
Jul 30
2024
|
High Cape Capital, LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,101,577
+18.76%
|
$2,101,577
$1.43 P/Share
|
|
Jun 21
2024
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,019
-5.81%
|
$24,057
$3.5 P/Share
|
|
Jun 21
2024
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,473
+14.01%
|
-
|
|
Jun 10
2024
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,327
-14.33%
|
$57,981
$3.47 P/Share
|
|
Jun 10
2024
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
54,167
+28.66%
|
-
|
|
Jun 10
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,920
-5.52%
|
$26,760
$3.47 P/Share
|
|
Jun 10
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+13.39%
|
-
|
|
Jun 10
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
7,900
-31.6%
|
$23,700
$3.47 P/Share
|
|
Jun 10
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
-
|
|
Mar 08
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
528
-0.43%
|
$1,584
$3.24 P/Share
|
|
Mar 08
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,288
+1.05%
|
-
|
|
Dec 28
2023
|
High Cape Capital, L.P. Director |
SELL
Other acquisition or disposition
|
Indirect |
1,436,077
-17.03%
|
-
|
|
Dec 28
2023
|
High Cape Capital, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,436,077
-17.03%
|
-
|
|
Sep 21
2023
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
70,053
+36.76%
|
-
|